Concepedia

Camille Vaganay

CV

Statistics

Publications

6

Citations

250

H-Index

6

Active since

2020

Affiliations

Inserm(Current)

Centre National de la Recherche Scientifique

Université Paris-Saclay

Assistance Publique – Hôpitaux de Paris

Hôpital Saint-Louis

Camille Vaganay is an author at Inserm specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2020–2022

6

Publications

6

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia

Bryann Pardieu, Justine Pasanisi, Frank Ling et al. · Leukemia · 2022 · 98 citations · Full text

, , +16

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor

Blandine Roux, Camille Vaganay, Jesse D. Vargas et al. · Science Translational Medicine · 2021 · 55 citations · Full text

, , +17

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Kevin Lin, Justine C. Rutter, Abigail Xie et al. · Nature Cancer · 2022 · 42 citations · Full text

, , +16

The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies

Angela Su, Frank Ling, Camille Vaganay et al. · Cancer Discovery · 2020 · 26 citations · Full text

, , +17

Screening of ETO2-GLIS2–induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia

Salima Benbarche, Cécile K. Lopez, Eralda Salataj et al. · Science Advances · 2022 · 16 citations · Full text

, , +17

1–5 of 6